However, in more recent years, there is compelling evidence the role that HER3 plays in the disease progression of different cancer types, as HER3 has been implicated in disease progression and drug resistance in bladder, breast, colorectal, and lung cancer among others. The gene discussed is ERBB3; the disease is lung cancer.